Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Antivirals Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Generic
  • 1.3.3 Branded
• 1.4 Market Segment by Application
  • 1.4.1 Global Antivirals Market Share by Application (2019-2025)
  • 1.4.2 Application I
  • 1.4.3 HIV
  • 1.4.4 Hepatitis
  • 1.4.5 HSV
  • 1.4.6 Influenza
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Antivirals Market Size
  • 2.1.1 Global Antivirals Revenue 2014-2025
  • 2.1.2 Global Antivirals Sales 2014-2025
• 2.2 Antivirals Growth Rate by Regions
  • 2.2.1 Global Antivirals Sales by Regions 2014-2019
  • 2.2.2 Global Antivirals Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Antivirals Sales by Manufacturers
  • 3.1.1 Antivirals Sales by Manufacturers 2014-2019
  • 3.1.2 Antivirals Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Antivirals Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antivirals Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Antivirals Market Concentration Ratio (CR5 and HHI)
• 3.3 Antivirals Price by Manufacturers
• 3.4 Key Manufacturers Antivirals Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Antivirals Market
• 3.6 Key Manufacturers Antivirals Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Generic Sales and Revenue (2014-2019)
  • 4.1.2 Branded Sales and Revenue (2014-2019)
• 4.2 Global Antivirals Sales Market Share by Type
• 4.3 Global Antivirals Revenue Market Share by Type
• 4.4 Antivirals Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Antivirals Sales by Application

6 United States

• 6.1 United States Antivirals Breakdown Data by Company
• 6.2 United States Antivirals Breakdown Data by Type
• 6.3 United States Antivirals Breakdown Data by Application

7 European Union

• 7.1 European Union Antivirals Breakdown Data by Company
• 7.2 European Union Antivirals Breakdown Data by Type
• 7.3 European Union Antivirals Breakdown Data by Application

8 China

• 8.1 China Antivirals Breakdown Data by Company
• 8.2 China Antivirals Breakdown Data by Type
• 8.3 China Antivirals Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Antivirals Breakdown Data by Company
• 9.2 Rest of World Antivirals Breakdown Data by Type
• 9.3 Rest of World Antivirals Breakdown Data by Application
• 9.4 Rest of World Antivirals Breakdown Data by Countries
  • 9.4.1 Rest of World Antivirals Sales by Countries
  • 9.4.2 Rest of World Antivirals Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Merck
  • 10.1.1 Merck Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Antivirals
  • 10.1.4 Antivirals Product Introduction
  • 10.1.5 Merck Recent Development
• 10.2 Johnson & Johnson
  • 10.2.1 Johnson & Johnson Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Antivirals
  • 10.2.4 Antivirals Product Introduction
  • 10.2.5 Johnson & Johnson Recent Development
• 10.3 Teva Pharmaceutical Industries
  • 10.3.1 Teva Pharmaceutical Industries Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Antivirals
  • 10.3.4 Antivirals Product Introduction
  • 10.3.5 Teva Pharmaceutical Industries Recent Development
• 10.4 GSK
  • 10.4.1 GSK Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Antivirals
  • 10.4.4 Antivirals Product Introduction
  • 10.4.5 GSK Recent Development
• 10.5 Mylan
  • 10.5.1 Mylan Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Antivirals
  • 10.5.4 Antivirals Product Introduction
  • 10.5.5 Mylan Recent Development
• 10.6 Gilead Sciences
  • 10.6.1 Gilead Sciences Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Antivirals
  • 10.6.4 Antivirals Product Introduction
  • 10.6.5 Gilead Sciences Recent Development
• 10.7 F. Hoffmann-La Roche
  • 10.7.1 F. Hoffmann-La Roche Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Antivirals
  • 10.7.4 Antivirals Product Introduction
  • 10.7.5 F. Hoffmann-La Roche Recent Development
• 10.8 Bristol-Myers-Squibb
  • 10.8.1 Bristol-Myers-Squibb Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Antivirals
  • 10.8.4 Antivirals Product Introduction
  • 10.8.5 Bristol-Myers-Squibb Recent Development
• 10.9 AbbVie
  • 10.9.1 AbbVie Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Antivirals
  • 10.9.4 Antivirals Product Introduction
  • 10.9.5 AbbVie Recent Development
• 10.10 Aurobindo Pharma
  • 10.10.1 Aurobindo Pharma Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Antivirals
  • 10.10.4 Antivirals Product Introduction
  • 10.10.5 Aurobindo Pharma Recent Development
• 10.11 Cipla
• 10.12 Dr Reddy’s

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Antivirals Sales Channels
  • 11.2.2 Antivirals Distributors
• 11.3 Antivirals Customers

12 Market Forecast

• 12.1 Global Antivirals Sales and Revenue Forecast 2019-2025
• 12.2 Global Antivirals Sales Forecast by Type
• 12.3 Global Antivirals Sales Forecast by Application
• 12.4 Antivirals Forecast by Regions
  • 12.4.1 Global Antivirals Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Antivirals Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
In 2019, the market size of Antivirals is 46000 million US$ and it will reach 65400 million US$ in 2025, growing at a CAGR of 4.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antivirals.

This report studies the global market size of Antivirals, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antivirals sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy’s

Market Segment by Product Type
Generic
Branded

Market Segment by Application
Application I
HIV
Hepatitis
HSV
Influenza

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Antivirals status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antivirals manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antivirals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025